SCHEMBL7835185

SCHEMBL7835185

CCCCn1ccc2[c]cccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 4/20 0.41
▸ CCND1 P24385 4/20 0.41
▸ TSHR P16473 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ SLC9A1 P19634 1/20 0.35
▸ GRM2 Q14416 1/20 0.35
▸ PGR P06401 1/20 0.34
▸ RORA P35398 1/20 0.34
▸ RORC P51449 1/20 0.34
▸ RORB Q92753 1/20 0.34
▸ KCNA3 P22001 3/20 0.33
▸ TLR8 Q9NR97 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3483158 0.90 CDK4 (0.37) CDK4CCND1TSHRLMNAHTT
SCHEMBL3483307 0.82 LMNA (0.33) CDK4CCND1LMNAHTTHTR2A
SCHEMBL1449745 0.79 CDK4 (0.37) CDK4CCND1TSHRLMNACNR2
SCHEMBL1450196 0.79 HTR2C (0.57) HTR2AHTR2C
SCHEMBL2784532 0.76 SLC9A1 (0.40) CDK4CCND1ALDH1A1SLC9A1PGR
SCHEMBL7132590 0.75 MEN1 (0.42) CDK4CCND1TSHRALDH1A1KMT2A
SCHEMBL1450364 0.72 NQO2 (0.47) ALDH1A1KMT2AKDM4EMEN1
SCHEMBL1451322 0.72 POLB (0.39) TSHRLMNAALDH1A1POLBKDM4E
SCHEMBL29374771 0.72 CDK4 (0.78) CDK4CCND1LMNAHTTKMT2A
SCHEMBL464099 0.72 CDK4 (0.78) CDK4CCND1LMNAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 — — EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 — — US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 — — EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 — — US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 — — US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 — — US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 — — US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 — — US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 — — EP disclosed
Send feedback